Work

An open label phase I/IIa study to evaluate the safety and efficacy of CCS1477 as monotherapy and in combination in patients with advanced solid/metastatic tumors.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.tps5089

Authors: Johann S. De Bono, Elena Cojocaru, Elizabeth Ruth Plummer, Tomasz Knurowski, Karen Clegg, Fay Ashby, Neil Pegg, William West, Anthony Nigel Brooks

Institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research, CellCentric (United Kingdom)

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947595611

Cites:

Cited by: 20

Related to: 10